Cordium Pharmaceuticals Pvt. Ltd. is a trusted Indian pharmaceutical exporter supplying Nupara® (Rucaparib) 200mg and 300mg Tablets to regulated and semi-regulated international markets. We support healthcare distributors, pharmaceutical importers, hospitals, oncology centers, and government procurement agencies across the globe.
What is Rucaparib?
Rucaparib is a targeted anticancer therapy belonging to the PARP (Poly ADP-Ribose Polymerase) inhibitor class. It is used in the management of certain ovarian cancers and other BRCA-mutated cancers as prescribed by oncology specialists.
Nupara® is manufactured under stringent quality standards to ensure safety, efficacy, and global compliance requirements.
Product Details
Product Name Nupara®
Generic Name Rucaparib
Strengths 200mg & 300mg Tablets
Dosage Form Oral Tablets
Therapeutic Category Oncology / PARP Inhibitor
Packaging Export-Oriented Packaging Available
Manufacturer & Exporter Cordium Pharmaceuticals Pvt. Ltd., India
Key Features of Nupara® (Rucaparib)
✔ High-quality pharmaceutical manufacturing standards
✔ Export-ready packaging solutions
✔ Competitive international pricing
✔ Reliable global supply chain support
✔ Bulk and institutional supply capability
✔ Documentation support for import registrations
✔ Timely worldwide delivery
Countries We Export Nupara® (Rucaparib)
Cordium Pharmaceuticals Pvt. Ltd. exports Nupara® (Rucaparib) 200mg & 300mg Tablets to major international markets including:
United States
Germany
United Kingdom
South Africa
United Arab Emirates
Brazil
Singapore
Australia
Canada
We continue to expand our oncology export network through strategic partnerships with pharmaceutical distributors and healthcare organizations worldwide.
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
As a leading oncology medicine exporter from India, Cordium Pharmaceuticals Pvt. Ltd. offers:
Consistent product availability
Global export expertise
Regulatory documentation assistance
Customized packaging solutions
Efficient logistics management
Competitive wholesale pricing
Long-term distributor partnerships
Applications of Rucaparib
Rucaparib is prescribed by qualified healthcare professionals for specific oncology indications based on approved guidelines and local regulatory requirements. Treatment decisions should always be made by licensed medical practitioners.
Looking for a Reliable Rucaparib Exporter from India?
Partner with Cordium Pharmaceuticals Pvt. Ltd. for dependable international supply of Nupara® (Rucaparib) 200mg & 300mg Tablets. We welcome inquiries from:
Pharmaceutical Importers
Oncology Distributors
Government Procurement Agencies
Hospitals & Cancer Centers
International Wholesalers
Tender Suppliers
What is Rucaparib?
Rucaparib is a targeted anticancer therapy belonging to the PARP (Poly ADP-Ribose Polymerase) inhibitor class. It is used in the management of certain ovarian cancers and other BRCA-mutated cancers as prescribed by oncology specialists.
Nupara® is manufactured under stringent quality standards to ensure safety, efficacy, and global compliance requirements.
Product Details
Product Name Nupara®
Generic Name Rucaparib
Strengths 200mg & 300mg Tablets
Dosage Form Oral Tablets
Therapeutic Category Oncology / PARP Inhibitor
Packaging Export-Oriented Packaging Available
Manufacturer & Exporter Cordium Pharmaceuticals Pvt. Ltd., India
Key Features of Nupara® (Rucaparib)
✔ High-quality pharmaceutical manufacturing standards
✔ Export-ready packaging solutions
✔ Competitive international pricing
✔ Reliable global supply chain support
✔ Bulk and institutional supply capability
✔ Documentation support for import registrations
✔ Timely worldwide delivery
Countries We Export Nupara® (Rucaparib)
Cordium Pharmaceuticals Pvt. Ltd. exports Nupara® (Rucaparib) 200mg & 300mg Tablets to major international markets including:
United States
Germany
United Kingdom
South Africa
United Arab Emirates
Brazil
Singapore
Australia
Canada
We continue to expand our oncology export network through strategic partnerships with pharmaceutical distributors and healthcare organizations worldwide.
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
As a leading oncology medicine exporter from India, Cordium Pharmaceuticals Pvt. Ltd. offers:
Consistent product availability
Global export expertise
Regulatory documentation assistance
Customized packaging solutions
Efficient logistics management
Competitive wholesale pricing
Long-term distributor partnerships
Applications of Rucaparib
Rucaparib is prescribed by qualified healthcare professionals for specific oncology indications based on approved guidelines and local regulatory requirements. Treatment decisions should always be made by licensed medical practitioners.
Looking for a Reliable Rucaparib Exporter from India?
Partner with Cordium Pharmaceuticals Pvt. Ltd. for dependable international supply of Nupara® (Rucaparib) 200mg & 300mg Tablets. We welcome inquiries from:
Pharmaceutical Importers
Oncology Distributors
Government Procurement Agencies
Hospitals & Cancer Centers
International Wholesalers
Tender Suppliers
Keywords
